Mar 5, 2026 08:46AM
Jan 5, 2026 04:35AM
Dec 24, 2025 06:44AM
Dec 23, 2025 08:03AM
Nov 13, 2025 06:41PM
Oct 27, 2025 06:50AM
Oct 9, 2025 05:37AM Increasing unusual call option volume: RVPH POET IE COTY SLNO TMQ NPWR FBL ARBE
Oct 8, 2025 09:46AM
Oct 8, 2025 06:18AM
Oct 6, 2025 04:37AM
Sep 29, 2025 05:59AM
Sep 15, 2025 09:04AM
Aug 14, 2025 05:48PM
Jun 26, 2025 08:41AM Reviva Pharmaceuticals (RVPH) Prices 20M Share Offering at $0.50/sh
Jun 25, 2025 04:18PM
Jun 2, 2025 07:02AM
May 30, 2025 04:13PM
May 23, 2025 07:48AM
May 20, 2025 07:02AM
May 15, 2025 07:00PM
Apr 9, 2025 09:33AM Reviva Pharmaceuticals (RVPH) PT Lowered to $14 at Benchmark
Mar 31, 2025 04:12PM
Jan 10, 2025 10:39AM
Jan 10, 2025 09:00AM
Dec 20, 2024 07:01AM
Dec 16, 2024 05:20PM
Dec 16, 2024 08:05AM
Nov 12, 2024 08:06AM Reviva Pharmaceuticals (RVPH) Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
Sep 23, 2024 07:06AM
Sep 9, 2024 08:04AM
Aug 21, 2024 06:17AM
Aug 15, 2024 04:46PM
Aug 6, 2024 08:02AM
Jul 11, 2024 10:33AM
Jul 9, 2024 08:12AM Reviva (RVPH) Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
Jun 11, 2024 06:41AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All